Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 5:22 pm Sale |
2022-01-31 | 13G | MEI Pharma, Inc. MEIP |
BLACKROCK INC BLK |
331,850 4.990% |
-2,643 (-0.79%) |
Filing History |
| 2022-01-31 5:49 pm Sale |
2021-12-31 | 13G | MEI Pharma, Inc. MEIP |
BLACKROCK INC BLK |
334,494 5.900% |
-14,890 (-4.26%) |
Filing History |
| 2021-02-16 3:44 pm Unchanged |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 08:32 am Purchase |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
UBS Oncology Impact Fund L.P. | 506,893 9.000% |
194,393 (+62.21%) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
Vivo Opportunity LLC | 165,017 2.800% |
-368,606 (-69.08%) |
Filing History |
| 2021-02-11 5:29 pm Sale |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
BIOTECHNOLOGY VALUE FUND L P | 279,466 4.900% |
-64,856 (-18.84%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
BLACKROCK INC BLK |
349,384 6.200% |
349,384 (New Position) |
Filing History |